Search results
Results from the WOW.Com Content Network
Provisional data from the Centers for Disease Control and Prevention (CDC) finds that of the nearly 110,000 drug overdoses in 2022, about three-quarters were attributed to opioids. Fentanyl and ...
Prescription drug overuse or non-medical prescription drug use is the use of prescription medications that is more than the prescribed amount, regardless of whether the original medical reason to take the drug is legitimate. [1] [2] A prescription drug is a drug substance prescribed by a doctor and intended to for individual use only. [3]
The CDC urges drug users to never use drugs alone to lower the risk of a fatal overdose. [5] Safe injection facilities create a space in which users do not have to inject drugs alone and are in the presence of personnel who can administer naloxone or provide emergency medical care if needed.
Drug overdose was the leading cause of injury death in 2013. Among people 25 to 64 years old, drug overdose caused more deaths than motor vehicle traffic crashes. There were 43,982 drug overdose deaths in the United States in 2013. Of these, 22,767 (51.8%) were related to prescription drugs. [33]
Frieden, the CDC director, said he has been stunned at the level of opposition to the medication from some in the treatment community. “I was at an event about prescription overdoses and I mentioned buprenorphine and I got booed,” he said. “I hope they would kind of understand that other people are going to want to use buprenorphine. …
Fentanyl has made headlines for driving overdose deaths, but the Centers for Disease Control and Prevention (CDC) is warning of the rise of an even deadlier drug. Last year, nearly 70% of all U.S ...
The DPH reported approximately 2,359 opioid-related overdose deaths in Massachusetts for 2022, according to the most recent data.That's up 3% from 2021 and a 16% increase from 2019.
Prescription drug monitoring programs, or PDMPs, are an example of one initiative proposed to alleviate effects of the opioid crisis. [1] The programs are designed to restrict prescription drug abuse by limiting a patient's ability to obtain similar prescriptions from multiple providers (i.e. “doctor shopping”) and reducing diversion of controlled substances.